1. Perseguer-Torregrosa Z, Orozco-Beltrán D, Gil-Guillen VF, Pita-Fernandez S, Carratalá-Munuera C, Pallares-Carratalá V, Lopez-Pineda A (2014) Magnitude of pharmacological nonadherence in hypertensive patients taking antihypertensive medication from a community pharmacy in Spain. J Manag Care Spec Pharm 20:1217–1225
2. García-Pérez LE, Alvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D (2013) Adherence to therapies in patients with type 2 diabetes. Diabetes Ther 4:175–194
3. Márquez Contreras E, Gil Guillén V, Casado Martínez JJ, Martel Claros N, De la Figuera von Wichmann M, Martín de Pablos JL, Atienza Martín F, Gros García T, Espinosa García J (2006) Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005. Aten Primaria 38:325–332
4. Piñeiro F, Gil V, Donis M, Orozco D, Torres MT, Merino J (1997) The validity of 6 indirect methods for assessing compliance with pharmacological treatment in dyslipidemias. Aten Primaria 19:465–468
5. Piñeiro F, Gil V, Pastor R, Donis M, Torres MT, Merino J (1998) Factors involved in the non-compliance of the pharmacologic treatment of dyslipidemia. Aten Primaria 21:425–430